Psychiatric and Nervous Drugs Market, Global Outlook and Forecast 2022-2028
A psychiatric and nervous drug (psychiatric or psychotropic medication) is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.
Mental health and well-being affect our daily lives. Psychotropic medications can be an important part of the tools available to help keep us well.
This report contains market size and forecasts of Psychiatric and Nervous Drugs in global, including the following market information:
Global Psychiatric and Nervous Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Psychiatric and Nervous Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Psychiatric and Nervous Drugs companies in 2021 (%)
The global Psychiatric and Nervous Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psychiatric and Nervous Drugs include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psychiatric and Nervous Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychiatric and Nervous Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Type, 2021 (%)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Application, 2021 (%)
Global Psychiatric and Nervous Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Psychiatric and Nervous Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Psychiatric and Nervous Drugs revenues share in global market, 2021 (%)
Key companies Psychiatric and Nervous Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Psychiatric and Nervous Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mental health and well-being affect our daily lives. Psychotropic medications can be an important part of the tools available to help keep us well.
This report contains market size and forecasts of Psychiatric and Nervous Drugs in global, including the following market information:
Global Psychiatric and Nervous Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Psychiatric and Nervous Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Psychiatric and Nervous Drugs companies in 2021 (%)
The global Psychiatric and Nervous Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psychiatric and Nervous Drugs include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psychiatric and Nervous Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychiatric and Nervous Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Type, 2021 (%)
- Antidepressants
- Anti-anxiety
- Antipsychotic
- Mood Stabilizing
- Stimulant Medications
- Others
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Psychiatric and Nervous Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Psychiatric and Nervous Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Psychiatric and Nervous Drugs revenues share in global market, 2021 (%)
Key companies Psychiatric and Nervous Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Psychiatric and Nervous Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Ely Lilly
- Actavis
- Mylan
- Randox
- Intellipharmaceutics
- Astrazeneca
- Lundbeck
- Allergan
- GSK
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- Chengdu Kanghong Pharmaceutical
- HUAHAI
- Zhejiang Jianfeng
- Beijing Winsunny Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Psychiatric and Nervous Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychiatric and Nervous Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PSYCHIATRIC AND NERVOUS DRUGS OVERALL MARKET SIZE
2.1 Global Psychiatric and Nervous Drugs Market Size: 2021 VS 2028
2.2 Global Psychiatric and Nervous Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Psychiatric and Nervous Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Psychiatric and Nervous Drugs Players in Global Market
3.2 Top Global Psychiatric and Nervous Drugs Companies Ranked by Revenue
3.3 Global Psychiatric and Nervous Drugs Revenue by Companies
3.4 Global Psychiatric and Nervous Drugs Sales by Companies
3.5 Global Psychiatric and Nervous Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Psychiatric and Nervous Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Psychiatric and Nervous Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Psychiatric and Nervous Drugs Players in Global Market
3.8.1 List of Global Tier 1 Psychiatric and Nervous Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Psychiatric and Nervous Drugs Market Size Markets, 2021 & 2028
4.1.2 Antidepressants
4.1.3 Anti-anxiety
4.1.4 Antipsychotic
4.1.5 Mood Stabilizing
4.1.6 Stimulant Medications
4.1.7 Others
4.2 By Type - Global Psychiatric and Nervous Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
4.2.2 By Type - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
4.2.3 By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Psychiatric and Nervous Drugs Sales & Forecasts
4.3.1 By Type - Global Psychiatric and Nervous Drugs Sales, 2017-2022
4.3.2 By Type - Global Psychiatric and Nervous Drugs Sales, 2023-2028
4.3.3 By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Psychiatric and Nervous Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Psychiatric and Nervous Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
5.2.2 By Application - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
5.2.3 By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Psychiatric and Nervous Drugs Sales & Forecasts
5.3.1 By Application - Global Psychiatric and Nervous Drugs Sales, 2017-2022
5.3.2 By Application - Global Psychiatric and Nervous Drugs Sales, 2023-2028
5.3.3 By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Psychiatric and Nervous Drugs Market Size, 2021 & 2028
6.2 By Region - Global Psychiatric and Nervous Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
6.2.2 By Region - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
6.2.3 By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Psychiatric and Nervous Drugs Sales & Forecasts
6.3.1 By Region - Global Psychiatric and Nervous Drugs Sales, 2017-2022
6.3.2 By Region - Global Psychiatric and Nervous Drugs Sales, 2023-2028
6.3.3 By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Psychiatric and Nervous Drugs Revenue, 2017-2028
6.4.2 By Country - North America Psychiatric and Nervous Drugs Sales, 2017-2028
6.4.3 US Psychiatric and Nervous Drugs Market Size, 2017-2028
6.4.4 Canada Psychiatric and Nervous Drugs Market Size, 2017-2028
6.4.5 Mexico Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Psychiatric and Nervous Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Psychiatric and Nervous Drugs Sales, 2017-2028
6.5.3 Germany Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.4 France Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.5 U.K. Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.6 Italy Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.7 Russia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.9 Benelux Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Psychiatric and Nervous Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Psychiatric and Nervous Drugs Sales, 2017-2028
6.6.3 China Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.4 Japan Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.5 South Korea Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.7 India Psychiatric and Nervous Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Psychiatric and Nervous Drugs Revenue, 2017-2028
6.7.2 By Country - South America Psychiatric and Nervous Drugs Sales, 2017-2028
6.7.3 Brazil Psychiatric and Nervous Drugs Market Size, 2017-2028
6.7.4 Argentina Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, 2017-2028
6.8.3 Turkey Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.4 Israel Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.6 UAE Psychiatric and Nervous Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Psychiatric and Nervous Drugs Major Product Offerings
7.1.4 Pfizer Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Ely Lilly
7.2.1 Ely Lilly Corporate Summary
7.2.2 Ely Lilly Business Overview
7.2.3 Ely Lilly Psychiatric and Nervous Drugs Major Product Offerings
7.2.4 Ely Lilly Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Ely Lilly Key News
7.3 Actavis
7.3.1 Actavis Corporate Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Psychiatric and Nervous Drugs Major Product Offerings
7.3.4 Actavis Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Actavis Key News
7.4 Mylan
7.4.1 Mylan Corporate Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Psychiatric and Nervous Drugs Major Product Offerings
7.4.4 Mylan Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Mylan Key News
7.5 Randox
7.5.1 Randox Corporate Summary
7.5.2 Randox Business Overview
7.5.3 Randox Psychiatric and Nervous Drugs Major Product Offerings
7.5.4 Randox Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Randox Key News
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Corporate Summary
7.6.2 Intellipharmaceutics Business Overview
7.6.3 Intellipharmaceutics Psychiatric and Nervous Drugs Major Product Offerings
7.6.4 Intellipharmaceutics Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Intellipharmaceutics Key News
7.7 Astrazeneca
7.7.1 Astrazeneca Corporate Summary
7.7.2 Astrazeneca Business Overview
7.7.3 Astrazeneca Psychiatric and Nervous Drugs Major Product Offerings
7.7.4 Astrazeneca Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Astrazeneca Key News
7.8 Lundbeck
7.8.1 Lundbeck Corporate Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Psychiatric and Nervous Drugs Major Product Offerings
7.8.4 Lundbeck Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Lundbeck Key News
7.9 Allergan
7.9.1 Allergan Corporate Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Psychiatric and Nervous Drugs Major Product Offerings
7.9.4 Allergan Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Allergan Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Psychiatric and Nervous Drugs Major Product Offerings
7.10.4 GSK Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Corporate Summary
7.11.2 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Business Overview
7.11.3 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.11.4 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Otsuka Pharmaceutical Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Psychiatric and Nervous Drugs Business Overview
7.12.3 Takeda Psychiatric and Nervous Drugs Major Product Offerings
7.12.4 Takeda Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Key News
7.13 NHU Group
7.13.1 NHU Group Corporate Summary
7.13.2 NHU Group Psychiatric and Nervous Drugs Business Overview
7.13.3 NHU Group Psychiatric and Nervous Drugs Major Product Offerings
7.13.4 NHU Group Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.13.5 NHU Group Key News
7.14 Shionogi
7.14.1 Shionogi Corporate Summary
7.14.2 Shionogi Business Overview
7.14.3 Shionogi Psychiatric and Nervous Drugs Major Product Offerings
7.14.4 Shionogi Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Shionogi Key News
7.15 APOTEX
7.15.1 APOTEX Corporate Summary
7.15.2 APOTEX Business Overview
7.15.3 APOTEX Psychiatric and Nervous Drugs Major Product Offerings
7.15.4 APOTEX Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.15.5 APOTEX Key News
7.16 Chengdu Kanghong Pharmaceutical
7.16.1 Chengdu Kanghong Pharmaceutical Corporate Summary
7.16.2 Chengdu Kanghong Pharmaceutical Business Overview
7.16.3 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.16.4 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Chengdu Kanghong Pharmaceutical Key News
7.17 HUAHAI
7.17.1 HUAHAI Corporate Summary
7.17.2 HUAHAI Business Overview
7.17.3 HUAHAI Psychiatric and Nervous Drugs Major Product Offerings
7.17.4 HUAHAI Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.17.5 HUAHAI Key News
7.18 Zhejiang Jianfeng
7.18.1 Zhejiang Jianfeng Corporate Summary
7.18.2 Zhejiang Jianfeng Business Overview
7.18.3 Zhejiang Jianfeng Psychiatric and Nervous Drugs Major Product Offerings
7.18.4 Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Zhejiang Jianfeng Key News
7.19 Beijing Winsunny Pharmaceutical
7.19.1 Beijing Winsunny Pharmaceutical Corporate Summary
7.19.2 Beijing Winsunny Pharmaceutical Business Overview
7.19.3 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.19.4 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Beijing Winsunny Pharmaceutical Key News
8 GLOBAL PSYCHIATRIC AND NERVOUS DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Psychiatric and Nervous Drugs Production Capacity, 2017-2028
8.2 Psychiatric and Nervous Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Psychiatric and Nervous Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PSYCHIATRIC AND NERVOUS DRUGS SUPPLY CHAIN ANALYSIS
10.1 Psychiatric and Nervous Drugs Industry Value Chain
10.2 Psychiatric and Nervous Drugs Upstream Market
10.3 Psychiatric and Nervous Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Psychiatric and Nervous Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Psychiatric and Nervous Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychiatric and Nervous Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PSYCHIATRIC AND NERVOUS DRUGS OVERALL MARKET SIZE
2.1 Global Psychiatric and Nervous Drugs Market Size: 2021 VS 2028
2.2 Global Psychiatric and Nervous Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Psychiatric and Nervous Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Psychiatric and Nervous Drugs Players in Global Market
3.2 Top Global Psychiatric and Nervous Drugs Companies Ranked by Revenue
3.3 Global Psychiatric and Nervous Drugs Revenue by Companies
3.4 Global Psychiatric and Nervous Drugs Sales by Companies
3.5 Global Psychiatric and Nervous Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Psychiatric and Nervous Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Psychiatric and Nervous Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Psychiatric and Nervous Drugs Players in Global Market
3.8.1 List of Global Tier 1 Psychiatric and Nervous Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Psychiatric and Nervous Drugs Market Size Markets, 2021 & 2028
4.1.2 Antidepressants
4.1.3 Anti-anxiety
4.1.4 Antipsychotic
4.1.5 Mood Stabilizing
4.1.6 Stimulant Medications
4.1.7 Others
4.2 By Type - Global Psychiatric and Nervous Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
4.2.2 By Type - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
4.2.3 By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Psychiatric and Nervous Drugs Sales & Forecasts
4.3.1 By Type - Global Psychiatric and Nervous Drugs Sales, 2017-2022
4.3.2 By Type - Global Psychiatric and Nervous Drugs Sales, 2023-2028
4.3.3 By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Psychiatric and Nervous Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Psychiatric and Nervous Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
5.2.2 By Application - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
5.2.3 By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Psychiatric and Nervous Drugs Sales & Forecasts
5.3.1 By Application - Global Psychiatric and Nervous Drugs Sales, 2017-2022
5.3.2 By Application - Global Psychiatric and Nervous Drugs Sales, 2023-2028
5.3.3 By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Psychiatric and Nervous Drugs Market Size, 2021 & 2028
6.2 By Region - Global Psychiatric and Nervous Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychiatric and Nervous Drugs Revenue, 2017-2022
6.2.2 By Region - Global Psychiatric and Nervous Drugs Revenue, 2023-2028
6.2.3 By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Psychiatric and Nervous Drugs Sales & Forecasts
6.3.1 By Region - Global Psychiatric and Nervous Drugs Sales, 2017-2022
6.3.2 By Region - Global Psychiatric and Nervous Drugs Sales, 2023-2028
6.3.3 By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Psychiatric and Nervous Drugs Revenue, 2017-2028
6.4.2 By Country - North America Psychiatric and Nervous Drugs Sales, 2017-2028
6.4.3 US Psychiatric and Nervous Drugs Market Size, 2017-2028
6.4.4 Canada Psychiatric and Nervous Drugs Market Size, 2017-2028
6.4.5 Mexico Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Psychiatric and Nervous Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Psychiatric and Nervous Drugs Sales, 2017-2028
6.5.3 Germany Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.4 France Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.5 U.K. Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.6 Italy Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.7 Russia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Psychiatric and Nervous Drugs Market Size, 2017-2028
6.5.9 Benelux Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Psychiatric and Nervous Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Psychiatric and Nervous Drugs Sales, 2017-2028
6.6.3 China Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.4 Japan Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.5 South Korea Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.6.7 India Psychiatric and Nervous Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Psychiatric and Nervous Drugs Revenue, 2017-2028
6.7.2 By Country - South America Psychiatric and Nervous Drugs Sales, 2017-2028
6.7.3 Brazil Psychiatric and Nervous Drugs Market Size, 2017-2028
6.7.4 Argentina Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, 2017-2028
6.8.3 Turkey Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.4 Israel Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Psychiatric and Nervous Drugs Market Size, 2017-2028
6.8.6 UAE Psychiatric and Nervous Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Psychiatric and Nervous Drugs Major Product Offerings
7.1.4 Pfizer Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Ely Lilly
7.2.1 Ely Lilly Corporate Summary
7.2.2 Ely Lilly Business Overview
7.2.3 Ely Lilly Psychiatric and Nervous Drugs Major Product Offerings
7.2.4 Ely Lilly Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Ely Lilly Key News
7.3 Actavis
7.3.1 Actavis Corporate Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Psychiatric and Nervous Drugs Major Product Offerings
7.3.4 Actavis Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Actavis Key News
7.4 Mylan
7.4.1 Mylan Corporate Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Psychiatric and Nervous Drugs Major Product Offerings
7.4.4 Mylan Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Mylan Key News
7.5 Randox
7.5.1 Randox Corporate Summary
7.5.2 Randox Business Overview
7.5.3 Randox Psychiatric and Nervous Drugs Major Product Offerings
7.5.4 Randox Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Randox Key News
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Corporate Summary
7.6.2 Intellipharmaceutics Business Overview
7.6.3 Intellipharmaceutics Psychiatric and Nervous Drugs Major Product Offerings
7.6.4 Intellipharmaceutics Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Intellipharmaceutics Key News
7.7 Astrazeneca
7.7.1 Astrazeneca Corporate Summary
7.7.2 Astrazeneca Business Overview
7.7.3 Astrazeneca Psychiatric and Nervous Drugs Major Product Offerings
7.7.4 Astrazeneca Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Astrazeneca Key News
7.8 Lundbeck
7.8.1 Lundbeck Corporate Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Psychiatric and Nervous Drugs Major Product Offerings
7.8.4 Lundbeck Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Lundbeck Key News
7.9 Allergan
7.9.1 Allergan Corporate Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Psychiatric and Nervous Drugs Major Product Offerings
7.9.4 Allergan Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Allergan Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Psychiatric and Nervous Drugs Major Product Offerings
7.10.4 GSK Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Corporate Summary
7.11.2 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Business Overview
7.11.3 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.11.4 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Otsuka Pharmaceutical Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Psychiatric and Nervous Drugs Business Overview
7.12.3 Takeda Psychiatric and Nervous Drugs Major Product Offerings
7.12.4 Takeda Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Key News
7.13 NHU Group
7.13.1 NHU Group Corporate Summary
7.13.2 NHU Group Psychiatric and Nervous Drugs Business Overview
7.13.3 NHU Group Psychiatric and Nervous Drugs Major Product Offerings
7.13.4 NHU Group Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.13.5 NHU Group Key News
7.14 Shionogi
7.14.1 Shionogi Corporate Summary
7.14.2 Shionogi Business Overview
7.14.3 Shionogi Psychiatric and Nervous Drugs Major Product Offerings
7.14.4 Shionogi Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Shionogi Key News
7.15 APOTEX
7.15.1 APOTEX Corporate Summary
7.15.2 APOTEX Business Overview
7.15.3 APOTEX Psychiatric and Nervous Drugs Major Product Offerings
7.15.4 APOTEX Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.15.5 APOTEX Key News
7.16 Chengdu Kanghong Pharmaceutical
7.16.1 Chengdu Kanghong Pharmaceutical Corporate Summary
7.16.2 Chengdu Kanghong Pharmaceutical Business Overview
7.16.3 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.16.4 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Chengdu Kanghong Pharmaceutical Key News
7.17 HUAHAI
7.17.1 HUAHAI Corporate Summary
7.17.2 HUAHAI Business Overview
7.17.3 HUAHAI Psychiatric and Nervous Drugs Major Product Offerings
7.17.4 HUAHAI Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.17.5 HUAHAI Key News
7.18 Zhejiang Jianfeng
7.18.1 Zhejiang Jianfeng Corporate Summary
7.18.2 Zhejiang Jianfeng Business Overview
7.18.3 Zhejiang Jianfeng Psychiatric and Nervous Drugs Major Product Offerings
7.18.4 Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Zhejiang Jianfeng Key News
7.19 Beijing Winsunny Pharmaceutical
7.19.1 Beijing Winsunny Pharmaceutical Corporate Summary
7.19.2 Beijing Winsunny Pharmaceutical Business Overview
7.19.3 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.19.4 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Beijing Winsunny Pharmaceutical Key News
8 GLOBAL PSYCHIATRIC AND NERVOUS DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Psychiatric and Nervous Drugs Production Capacity, 2017-2028
8.2 Psychiatric and Nervous Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Psychiatric and Nervous Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PSYCHIATRIC AND NERVOUS DRUGS SUPPLY CHAIN ANALYSIS
10.1 Psychiatric and Nervous Drugs Industry Value Chain
10.2 Psychiatric and Nervous Drugs Upstream Market
10.3 Psychiatric and Nervous Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Psychiatric and Nervous Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Psychiatric and Nervous Drugs in Global Market
Table 2. Top Psychiatric and Nervous Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Psychiatric and Nervous Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Psychiatric and Nervous Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Psychiatric and Nervous Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Psychiatric and Nervous Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Psychiatric and Nervous Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Psychiatric and Nervous Drugs Product Type
Table 9. List of Global Tier 1 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Psychiatric and Nervous Drugs Product Offerings
Table 48. Pfizer Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Ely Lilly Corporate Summary
Table 50. Ely Lilly Psychiatric and Nervous Drugs Product Offerings
Table 51. Ely Lilly Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Actavis Corporate Summary
Table 53. Actavis Psychiatric and Nervous Drugs Product Offerings
Table 54. Actavis Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan Corporate Summary
Table 56. Mylan Psychiatric and Nervous Drugs Product Offerings
Table 57. Mylan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Randox Corporate Summary
Table 59. Randox Psychiatric and Nervous Drugs Product Offerings
Table 60. Randox Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Intellipharmaceutics Corporate Summary
Table 62. Intellipharmaceutics Psychiatric and Nervous Drugs Product Offerings
Table 63. Intellipharmaceutics Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Astrazeneca Corporate Summary
Table 65. Astrazeneca Psychiatric and Nervous Drugs Product Offerings
Table 66. Astrazeneca Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Lundbeck Corporate Summary
Table 68. Lundbeck Psychiatric and Nervous Drugs Product Offerings
Table 69. Lundbeck Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Allergan Corporate Summary
Table 71. Allergan Psychiatric and Nervous Drugs Product Offerings
Table 72. Allergan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Psychiatric and Nervous Drugs Product Offerings
Table 75. GSK Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Otsuka Pharmaceutical Corporate Summary
Table 77. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 78. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Takeda Corporate Summary
Table 80. Takeda Psychiatric and Nervous Drugs Product Offerings
Table 81. Takeda Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. NHU Group Corporate Summary
Table 83. NHU Group Psychiatric and Nervous Drugs Product Offerings
Table 84. NHU Group Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Shionogi Corporate Summary
Table 86. Shionogi Psychiatric and Nervous Drugs Product Offerings
Table 87. Shionogi Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. APOTEX Corporate Summary
Table 89. APOTEX Psychiatric and Nervous Drugs Product Offerings
Table 90. APOTEX Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Chengdu Kanghong Pharmaceutical Corporate Summary
Table 92. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 93. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. HUAHAI Corporate Summary
Table 95. HUAHAI Psychiatric and Nervous Drugs Product Offerings
Table 96. HUAHAI Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Zhejiang Jianfeng Corporate Summary
Table 98. Zhejiang Jianfeng Psychiatric and Nervous Drugs Product Offerings
Table 99. Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Beijing Winsunny Pharmaceutical Corporate Summary
Table 101. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 102. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Psychiatric and Nervous Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Psychiatric and Nervous Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Psychiatric and Nervous Drugs Production by Region, 2017-2022 (K Units)
Table 106. Global Psychiatric and Nervous Drugs Production by Region, 2023-2028 (K Units)
Table 107. Psychiatric and Nervous Drugs Market Opportunities & Trends in Global Market
Table 108. Psychiatric and Nervous Drugs Market Drivers in Global Market
Table 109. Psychiatric and Nervous Drugs Market Restraints in Global Market
Table 110. Psychiatric and Nervous Drugs Raw Materials
Table 111. Psychiatric and Nervous Drugs Raw Materials Suppliers in Global Market
Table 112. Typical Psychiatric and Nervous Drugs Downstream
Table 113. Psychiatric and Nervous Drugs Downstream Clients in Global Market
Table 114. Psychiatric and Nervous Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Psychiatric and Nervous Drugs in Global Market
Table 2. Top Psychiatric and Nervous Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Psychiatric and Nervous Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Psychiatric and Nervous Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Psychiatric and Nervous Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Psychiatric and Nervous Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Psychiatric and Nervous Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Psychiatric and Nervous Drugs Product Type
Table 9. List of Global Tier 1 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Psychiatric and Nervous Drugs Product Offerings
Table 48. Pfizer Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Ely Lilly Corporate Summary
Table 50. Ely Lilly Psychiatric and Nervous Drugs Product Offerings
Table 51. Ely Lilly Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Actavis Corporate Summary
Table 53. Actavis Psychiatric and Nervous Drugs Product Offerings
Table 54. Actavis Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan Corporate Summary
Table 56. Mylan Psychiatric and Nervous Drugs Product Offerings
Table 57. Mylan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Randox Corporate Summary
Table 59. Randox Psychiatric and Nervous Drugs Product Offerings
Table 60. Randox Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Intellipharmaceutics Corporate Summary
Table 62. Intellipharmaceutics Psychiatric and Nervous Drugs Product Offerings
Table 63. Intellipharmaceutics Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Astrazeneca Corporate Summary
Table 65. Astrazeneca Psychiatric and Nervous Drugs Product Offerings
Table 66. Astrazeneca Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Lundbeck Corporate Summary
Table 68. Lundbeck Psychiatric and Nervous Drugs Product Offerings
Table 69. Lundbeck Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Allergan Corporate Summary
Table 71. Allergan Psychiatric and Nervous Drugs Product Offerings
Table 72. Allergan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Psychiatric and Nervous Drugs Product Offerings
Table 75. GSK Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Otsuka Pharmaceutical Corporate Summary
Table 77. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 78. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Takeda Corporate Summary
Table 80. Takeda Psychiatric and Nervous Drugs Product Offerings
Table 81. Takeda Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. NHU Group Corporate Summary
Table 83. NHU Group Psychiatric and Nervous Drugs Product Offerings
Table 84. NHU Group Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Shionogi Corporate Summary
Table 86. Shionogi Psychiatric and Nervous Drugs Product Offerings
Table 87. Shionogi Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. APOTEX Corporate Summary
Table 89. APOTEX Psychiatric and Nervous Drugs Product Offerings
Table 90. APOTEX Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Chengdu Kanghong Pharmaceutical Corporate Summary
Table 92. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 93. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. HUAHAI Corporate Summary
Table 95. HUAHAI Psychiatric and Nervous Drugs Product Offerings
Table 96. HUAHAI Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Zhejiang Jianfeng Corporate Summary
Table 98. Zhejiang Jianfeng Psychiatric and Nervous Drugs Product Offerings
Table 99. Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Beijing Winsunny Pharmaceutical Corporate Summary
Table 101. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 102. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Psychiatric and Nervous Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Psychiatric and Nervous Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Psychiatric and Nervous Drugs Production by Region, 2017-2022 (K Units)
Table 106. Global Psychiatric and Nervous Drugs Production by Region, 2023-2028 (K Units)
Table 107. Psychiatric and Nervous Drugs Market Opportunities & Trends in Global Market
Table 108. Psychiatric and Nervous Drugs Market Drivers in Global Market
Table 109. Psychiatric and Nervous Drugs Market Restraints in Global Market
Table 110. Psychiatric and Nervous Drugs Raw Materials
Table 111. Psychiatric and Nervous Drugs Raw Materials Suppliers in Global Market
Table 112. Typical Psychiatric and Nervous Drugs Downstream
Table 113. Psychiatric and Nervous Drugs Downstream Clients in Global Market
Table 114. Psychiatric and Nervous Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Psychiatric and Nervous Drugs Segment by Type
Figure 2. Psychiatric and Nervous Drugs Segment by Application
Figure 3. Global Psychiatric and Nervous Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Psychiatric and Nervous Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Psychiatric and Nervous Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Psychiatric and Nervous Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Psychiatric and Nervous Drugs Revenue in 2021
Figure 9. By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 19. US Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 24. Germany Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 33. China Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Psychiatric and Nervous Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Psychiatric and Nervous Drugs by Region, 2021 VS 2028
Figure 50. Psychiatric and Nervous Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Psychiatric and Nervous Drugs Segment by Type
Figure 2. Psychiatric and Nervous Drugs Segment by Application
Figure 3. Global Psychiatric and Nervous Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Psychiatric and Nervous Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Psychiatric and Nervous Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Psychiatric and Nervous Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Psychiatric and Nervous Drugs Revenue in 2021
Figure 9. By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 19. US Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 24. Germany Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 33. China Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Psychiatric and Nervous Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Psychiatric and Nervous Drugs by Region, 2021 VS 2028
Figure 50. Psychiatric and Nervous Drugs Industry Value Chain
Figure 51. Marketing Channels
